Kratom Does Not Cause False-Positive Buprenorphine Results on Standard UDS
Kratom will not produce a false-positive result for buprenorphine on standard urine drug screens. These are chemically distinct substances with different metabolic pathways that do not cross-react on immunoassay testing.
Why This Matters
Kratom contains alkaloids (primarily mitragynine and 7-hydroxymitragynine) that act on opioid receptors but have completely different chemical structures from buprenorphine 1. Standard immunoassay drug screens detect specific drug metabolites through antibody binding, and the structural differences between kratom alkaloids and buprenorphine prevent cross-reactivity.
What Actually Causes False-Positive Buprenorphine Results
The evidence identifies specific substances that can cause false-positive buprenorphine screens:
- Tramadol: Multiple studies confirm tramadol can cause false-positive buprenorphine immunoassays, particularly with certain assay types (CEDIA at 5 ng/mL cutoff) 2
- Loperamide (Imodium): At high concentrations (>12.2 mg/L), the metabolite N-desmethyl loperamide can produce false-positive buprenorphine results on CEDIA assays 3
- High-dose opiates: Opiate concentrations >2000 µg/L can cause cross-reactivity with CEDIA buprenorphine immunoassays 4
Kratom is notably absent from this list despite extensive literature on drug testing interference 1.
Clinical Implications for Kratom Testing
If you need to detect kratom use, understand these key points:
- Kratom requires specialized testing: Standard drug panels do not detect kratom alkaloids 5
- Specific kratom metabolite testing is necessary: Gas chromatography-mass spectrometry (GC-MS) targeting mitragynine metabolites (16-carboxy-mitragynine, 9-O-demethyl-mitragynine) is required 5
- Detection window varies: Kratom metabolites can be detected in urine, but timing depends on dose, plant type, and individual metabolism 5
Important Caveats
Confirmatory testing is essential when buprenorphine immunoassay results don't match clinical presentation 1. False-positives occur with screening immunoassays due to cross-reactivity, but confirmatory testing (GC-MS or LC-MS/MS) is highly specific and will differentiate true buprenorphine from interfering substances 1.
If a patient reports kratom use and has a positive buprenorphine screen, consider:
- Concurrent buprenorphine use (kratom users may use buprenorphine for kratom withdrawal 6, 7, 8)
- Presence of tramadol or loperamide 3, 2
- Request confirmatory testing to resolve the discrepancy
The bottom line: A positive buprenorphine screen in a kratom user indicates either true buprenorphine use or interference from a different substance—not kratom itself.